|
Name: 4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1 H-indazole-3-carboxamide)
Type:
AKA: 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
4-CN-Cumyl-BUTINACA, a synthetic cannabinoid, was developed in the 2010s as part of research into cannabinoid receptors. It is known for its psychoactive effects and has been used recreationally. Its use has led to regulatory measures due to safety concerns and abuse potential.
|
|
V. Legal Information
4-CN-Cumyl-BUTINACA, a synthetic cannabinoid, is regulated under analog laws due to its psychoactive effects. In the US, it may be controlled under the Federal Analog Act if deemed similar to other controlled substances.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
4-CN-Cumyl-BUTINACA is a synthetic cannabinoid with psychoactive effects. It acts as an upper, producing euphoria and altered perception. Short-term use can lead to intense effects, while long-term impacts are not well documented. Overdose risks include severe psychological effects and potential toxicity. Safe use is uncertain due to limited research. Recent studies focus on its potency and potential health risks.  |
|
VII. Psychological Effects
4-CN-Cumyl-BUTINACA, a synthetic cannabinoid, affects cannabinoid receptors, causing altered mood and perception. Immediate effects include euphoria and relaxation, with long-term use potentially leading to cognitive impairments and psychological issues. Research focuses on its safety and psychological impact.
 |
|
VIII. Culture
4-CN-CUMYL-BUTINACA is a synthetic cannabinoid mimicking THC effects, classifying it as a downer. Short-term use induces euphoria, relaxation, and altered perception, while long-term use may lead to cognitive impairment and psychological dependence. Overdose can result in severe anxiety, hallucinations, and cardiovascular issues. Safe dosages are not well-established, with lower doses advised. Recent research highlights its abuse potential and health risks. Physical signs include red eyes, dry mouth, and altered mental state.
 |